Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.
D000328:Adult; D001741:Black or African American; D000818:Animals; D002642:Chick Embryo; D002689:Chlamydia; D002986:Clinical Trials as Topic; D003168:Complement Fixation Tests; D003231:Conjunctivitis / Q000151:congenital* / Q000254:growth & development / Q000276:immunology; D003235:Conjunctivitis, Inclusion; D005007:Ethnology; D005128:Eye Diseases / Q000293:injuries; D005455:Fluorescent Antibody Technique; D006652:Histological Techniques; D006801:Humans; D066298:In Vitro Techniques; D007181:Inclusion Bodies, Viral; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D008297:Male; D008875:Middle Aged; D013444:Sulfisoxazole / Q000008:administration & dosage; D013752:Tetracycline / Q000008:administration & dosage; D014141:Trachoma; D014776:Virus Cultivation; D044465:White People
D013444:Sulfisoxazole; D013752:Tetracycline